Basilico, IT
Alberto Basilico, Caronno Pertusella-Varese IT
Patent application number | Description | Published |
---|---|---|
20100126839 | ELECTRONIC MANUALLY CONTROLLABLE ADJUSTMENT DEVICE - An electronic manually controllable adjustment device for adjusting electric power provided to an electric load connectable to the device is described. The device comprises first switching elements, a tilting control button which may interact with the first switching elements, and first hinge elements for defining a first hinge axis allowing rotation of the control button around the first axis between a first operating position and a second operating position. The control button can interact with the first switching elements when reaching the first and second operating position. The device further comprises second switching elements and second hinge elements. The second hinge elements can define a second hinge axis perpendicular to the first hinge axis and allow rotation of the control button around the second hinge axis for actuation of the second switching elements. | 05-27-2010 |
Andrea Basilico, Lomazzo (como) IT
Patent application number | Description | Published |
---|---|---|
20080294996 | CUSTOMIZED RETAILER PORTAL WITHIN AN ANALYTIC PLATFORM - The methods and systems disclosed herein include an analytic platform, with a customized retailer portal application, that may be used to perform data projection and release methodologies in order to create an integrated, flexible, actionable view of data such as data relating to consumers, consumer behavior, commodity sales, and other commercial activities like those pertaining to relationships between consumers and stores. | 11-27-2008 |
20090006156 | ASSOCIATING A GRANTING MATRIX WITH AN ANALYTIC PLATFORM - Systems and methods presented may involve specifying an availability condition associated with a component of an analytic platform. It may involve storing the availability condition in a matrix. It may involve using the matrix to determine access to the component of the analytic platform. | 01-01-2009 |
20090006788 | ASSOCIATING A FLEXIBLE DATA HIERARCHY WITH AN AVAILABILITY CONDITION IN A GRANTING MATRIX - Systems and methods are presented that may involve specifying an availability condition associated with a data hierarchy in a database. It may also involve storing the availability condition in a matrix and using the matrix to determine access to data in the data hierarchy. In embodiments, the data hierarchy may be a flexible data hierarchy wherein a selected dimension of data within the hierarchy may be held temporarily fixed while flexibly accessing other dimensions of the data. In embodiments, the process may further involve specifying an availability condition, wherein the specification of the availability condition does not require modification of the datum or restatement of the database. | 01-01-2009 |
Andrea Basilico, Manera Di Lomazzo (como) IT
Patent application number | Description | Published |
---|---|---|
20080294372 | PROJECTION FACILITY WITHIN AN ANALYTIC PLATFORM - In embodiments of the present invention improved capabilities are described for using an analytic platform to obtain a projection. A core information matrix may be developed for data set, where the core information matrix may include regions representing the statistical characteristics of alternative projection techniques that may be applied to the data set. In addition, a user may be provided with an interface whereby the user may observe the regions of the core information matrix to facilitate selecting an appropriate projection technique. | 11-27-2008 |
20080294583 | SIMILARITY MATCHING OF A COMPETITOR'S PRODUCTS - In embodiments of the present invention improved capabilities are described for identifying a classification scheme associated with product attributes of a grouping of products of an entity, receiving a record of data relating to an item of a competitor to the entity, the classification of which is uncertain, receiving a dictionary of attributes associated with products, and assigning a product code to the item, based on probabilistic matching among the attributes in the classification scheme, the attributes in the dictionary of attributes and at least one known attribute of the item. | 11-27-2008 |
Andrea Basilico, Como IT
Patent application number | Description | Published |
---|---|---|
20080288522 | CREATING AND STORING A DATA FIELD ALTERATION DATUM USING AN ANALYTIC PLATFORM - A method for reading the altered data field in accordance with the field alteration data is provided. The method may include altering a data field characteristic of a data field in a data table, saving the field alteration datum associated with the alteration in a data storage facility, submitting a query requiring the use of the data field in the dataset and reading the altered data field in accordance with the field alteration data. The alteration may generate a field alteration datum and a component of the query may consist of reading the field alteration data. | 11-20-2008 |
Christina Basilico, Pavarolo IT
Patent application number | Description | Published |
---|---|---|
20140205606 | ANTI C-MET ANTIBODIES - The present invention relates to antibodies that specifically bind to the human c-Met receptor protein and that act as strict antagonists of hepatocyte growth factor (HGF)-mediated activation of the c-Met receptor and also inhibit HGF-independent activation of the human c-Met protein. | 07-24-2014 |
Cristina Basilico, Pavarolo (to) IT
Patent application number | Description | Published |
---|---|---|
20120108789 | High affinity binding site of HGFR and methods for identification of antagonists thereof - Use of a polynucleotide encoding or a polypeptide comprising at least the extra-cellular IPT-3 and IPT-4 domains of hepatocyte growth factor receptor for the screening and/or development of pharmacologically active agents useful in the treatment of cancer, preferably a cancer with dysregulation of hepatocyte growth factor receptor. | 05-03-2012 |
20120115219 | High affinity binding site of HGFR and methods for identification of antagonists thereof - Use of a polynucleotide encoding or a polypeptide comprising at least the extra-cellular IPT-3 and IPT-4 domains of hepatocyte growth factor receptor for the screening and/or development of pharmacologically active agents useful in the treatment of cancer, preferably a cancer with dysregulation of hepatocyte growth factor receptor. | 05-10-2012 |
20130183690 | HIGH AFFINITY BINDING SITE OF HGFR AND METHODS FOR IDENTIFICATION OF ANTAGONISTS THEREOF - Use of a polynucleotide encoding or a polypeptide comprising at least the extra-cellular IPT-3 and IPT-4 domains of hepatocyte growth factor receptor for the screening and/or development of pharmacologically active agents useful in the treatment of cancer, preferably a cancer with dysregulation of hepatocyte growth factor receptor. | 07-18-2013 |
Cristina Basilico, Pavarolo IT
Patent application number | Description | Published |
---|---|---|
20090298079 | HIGH AFFINITY BINDING SITE OF HGFR AND METHODS FOR IDENTIFICATION OF ANTAGONISTS THEREOF - Use of a polynucleotide encoding or a polypeptide comprising at least the extracellular IPT-3 and IPT-4 domains of hepatocyte growth factor receptor for the screening and/or development of pharmacologically active agents useful in the treatment of cancer, preferably a cancer with dysregulation of hepatocyte growth factor receptor. | 12-03-2009 |
20120148607 | ANTI C-MET ANTIBODIES - The present invention relates to antibodies that specifically bind to the human c-Met receptor protein and that act as strict antagonists of hepatocyte growth factor (HGF)-mediated activation of the c-Met receptor and also inhibit HGF-independent activation of the human c-Met protein. | 06-14-2012 |
20120156206 | C-MET ANTIBODY COMBINATIONS - The invention provides a product combination or composition, and also multispecific antibodies comprising two or more antigen-binding sites (as antibodies or antigen binding fragments thereof), wherein two the antigen-binding bind to distinct non-overlapping epitopes of the human c-Met protein. The product combination or composition or multispecific antibody inhibits HGF-independent activation of the human c-Met receptor protein. | 06-21-2012 |